Ideaya Biosciences

Pharma

Roche-Innovent, AstraZeneca, Viatris and more—Fierce Pharma Asia

Roche and Ideaya separately licensed ADCs from Chinese firms. Experts weighed in on AZ's China probes. A Viatris plant got a warning letter. And more.

Angus Liu Jan 3, 2025 8:37am

Ideaya hires Gilead leader to head up commercialization push

Nov 19, 2024 10:34am

Merck and BioNTech's I-O bispecific buys—Fierce Pharma Asia

Nov 15, 2024 8:20am